444 related articles for article (PubMed ID: 31115372)
21. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
22. High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.
Guirat-Dhouib N; Mezri M; Hmida H; Mellouli F; Kaabi H; Ouderni M; Zouari B; Hmida S; Bejaoui M
Transfus Apher Sci; 2011 Oct; 45(2):199-202. PubMed ID: 21889408
[TBL] [Abstract][Full Text] [Related]
23. Alloimmunization in transfused patients with constitutional anemias in Norway.
Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
[TBL] [Abstract][Full Text] [Related]
24. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
[TBL] [Abstract][Full Text] [Related]
25. Red cell alloantibodies in patients with thalassemia.
Spanos T; Karageorga M; Ladis V; Peristeri J; Hatziliami A; Kattamis C
Vox Sang; 1990; 58(1):50-5. PubMed ID: 2316211
[TBL] [Abstract][Full Text] [Related]
26. Red cell antigen phenotypes in blood donors & thalassaemia patients for creation of red cell antigen-matched inventory.
Kulkarni S; Choudhary B; Gogri H; Sharma J; Madkaikar M
Indian J Med Res; 2020 Sep; 152(3):273-279. PubMed ID: 33107487
[TBL] [Abstract][Full Text] [Related]
27. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
Sins JW; Biemond BJ; van den Bersselaar SM; Heijboer H; Rijneveld AW; Cnossen MH; Kerkhoffs JL; van Meurs AH; von Ronnen FB; Zalpuri S; de Rijke YB; Ellen van der Schoot C; de Haas M; van der Bom JG; Fijnvandraat K
Am J Hematol; 2016 Aug; 91(8):763-9. PubMed ID: 27102719
[TBL] [Abstract][Full Text] [Related]
28. Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods.
Campbell-Lee SA; Gvozdjan K; Choi KM; Chen YF; Saraf SL; Hsu LL; Gordeuk VR; Strauss RG; Triulzi DJ
Transfusion; 2018 Jul; 58(7):1588-1596. PubMed ID: 29570817
[TBL] [Abstract][Full Text] [Related]
29. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
McPherson ME; Anderson AR; Castillejo MI; Hillyer CD; Bray RA; Gebel HM; Josephson CD
Pediatr Blood Cancer; 2010 Apr; 54(4):552-8. PubMed ID: 19890898
[TBL] [Abstract][Full Text] [Related]
30. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
[TBL] [Abstract][Full Text] [Related]
31. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
32. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
Hendrickson JE; Hod EA; Perry JR; Ghosh S; Chappa P; Adisa O; Kean LS; Ofori-Acquah SF; Archer DR; Spitalnik SL; Zimring JC
Transfusion; 2012 Feb; 52(2):231-40. PubMed ID: 21790627
[TBL] [Abstract][Full Text] [Related]
33. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
[TBL] [Abstract][Full Text] [Related]
34. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
35. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
Shih AW; Yan MTS; Elahie AL; Barty RL; Liu Y; Berardi P; Azzam M; Siddiqui R; Parvizian MK; Mcdougall T; Heddle NM; Al-Habsi KS; Goldman M; Cote J; Athale U; Verhovsek MM
Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
[TBL] [Abstract][Full Text] [Related]
36. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
37. Study of the Frequency and Specificity of Red Cell Antibodies in Patients with Hemoglobinopathies.
Wilson MM; El Masry MMW; El-Ghamrawy MK; El-Hadi NA; Abou-Elalla AA
Indian J Hematol Blood Transfus; 2023 Oct; 39(4):579-585. PubMed ID: 37786822
[TBL] [Abstract][Full Text] [Related]
38. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.
Matteocci A; Pierelli L
Vox Sang; 2014 Apr; 106(3):197-208. PubMed ID: 24117723
[TBL] [Abstract][Full Text] [Related]
39. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
